COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 2025: Articles 20241-20250  | Next

Nasopharyngeal Panbio COVID-19 antigen performed at point-of-care has a high sensitivity in symptomatic and asymptomatic patients with higher risk for transmission and older age
Masia, M., Fernandez-Gonzalez, M., Sanchez, M., Carvajal, M., Garcia, J. A., Gonzalo, N., Ortiz de la Tabla, V., Agullo, V., Candela, I., Guijarro, J., Gutierrez, J. A., De Gregorio, C., Gutierrez, F.
10.1101/2020.11.16.20230003 — Posted: 2020-11-17
The total number and mass of SARS-CoV-2 virions in an infected person
Sender, R., Bar-On, Y. M., Flamholz, A., Gleizer, S., Bernsthein, B., Phillips, R., Milo, R.
10.1101/2020.11.16.20232009 — Posted: 2020-11-17
Deconditioning in people living with dementia during the COVID-19 pandemic: findings from the Promoting Activity, Independence and Stability in Early Dementia (PrAISED) process evaluation
Di Lorito, C., Masud, T., Gladman, J., Godfrey, M., Dunlop, M., Harwood, R. H.
10.1101/2020.11.16.20231100 — Posted: 2020-11-17
Intranasal Administration of ACIS KEPTIDE™ Prevents SARS-CoV2-Induced Acute Toxicity in K18-hACE2 Humanized Mouse Model of COVID-19: A Mechanistic Insight for the Prophylactic Role of KEPTIDE™ in COVID-19
Gottschalk, G., Keating, J. F., Kesler, K., Knox, K., Roy, A.
10.1101/2020.11.13.378257 — Posted: 2020-11-16
An ancient coronavirus-like epidemic drove adaptation in East Asians from 25,000 to 5,000 years ago
Souilmi, Y., Lauterbur, M. E., Tobler, R., Huber, C. D., Johar, A. S., Enard, D.
10.1101/2020.11.16.385401 — Posted: 2020-11-16
Recurrent mutations in SARS-CoV-2 genomes isolated from mink point to rapid host-adaptation
van Dorp, L., Tan, C. C., Lam, S. D., Richard, D., Owen, C., Berchtold, D., Orengo, C., Balloux, F.
10.1101/2020.11.16.384743 — Posted: 2020-11-16 Discussion: Onsite | Offsite
Transcriptome Profiling of different types of human respiratory tract cells infected by SARS-CoV-2 Highlight an unique Role for Inflammatory and Interferon Response
Yang, M., Lei, L., Cao, Q., Yang, Y., Wang, J., Jiang, X., Huang, K., Lai, J., Qing, L., Wang, Y., Liu, Y.
10.1101/2020.11.15.383927 — Posted: 2020-11-16
Analysis of SARS-CoV-2 spike glycosylation reveals shedding of a vaccine candidate
Brun, J., Vasiljevic, S., Gangadharan, B., Hensen, M., Chandran, A. V., Hill, M. L., Kiappes, J. L., Dwek, R. A., Alonzi, D. S., Struwe, W. B., Zitzmann, N.
10.1101/2020.11.16.384594 — Posted: 2020-11-16
Trimeric SARS-CoV-2 Spike proteins produced from CHO-cells in bioreactors are high-quality antigens
Pino, P., Kint, J., Kiseljak, D., Agnolon, V., Corradin, G., KAJAVA, A. V., Rovero, P., Dijkman, R., Hartog, G. d., McLellan, J. S., Byrne, P., Wurm, M. J., Wurm, F. M.
10.1101/2020.11.15.382044 — Posted: 2020-11-16
Gene Expression Meta-Analysis Identifies Molecular Changes Associated with SARS-CoV Infection in Lungs
Park, A., Harris, L.
10.1101/2020.11.14.382697 — Posted: 2020-11-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).